Trial site
Penn State Milton S. Hershey Medical Center and Children's Hospital
- 12running trials
- 1closed trial
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers13 trials
- Neuroblastoma10 trials
- Sarcoma4 trials
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Meningioma1 trial
- Phase
- Phase 28 trials
- Phase 1/22 trials
- Phase 11 trial
- Status
- Recruiting10 trials
- Active, not recruiting2 trials
- Completed1 trial
- Lead sponsor
- Giselle Sholler9 trials
- Milton S. Hershey Medical Center3 trials
- University of Florida1 trial
Running trials
Recruiting
Naxitamab Enabled Transplant-Free Study in High-Risk Neuroblastoma
Recruiting
Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Recruiting
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Recruiting
PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy
Recruiting
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Recruiting
Active, not recruiting
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Active, not recruiting
Recruiting
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers10 recruiting
- Neuroblastoma7 recruiting
- Sarcoma3 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026